GLP-1 clinical trials in Tennessee: 27 recruiting now
40 sites in 12 Tennessee cities. Registry checked October 16, 2026.
Screening for a study can take weeks. Two cash programs to check.
No insurance needed.
- SnagRxSponsored$99 a monthcompounded semaglutideCheck price →SnagRx's homepage shows its 12-month prepaid prices first
- MedviSponsored$299 a monthFirst month $179compounded semaglutideCheck price →Straight to MEDVi's GLP-1 sign-up
Weight-loss studies (7)
Weight-loss study of cagrisema
Where: Jackson, Kingsport, Memphis and 2 more cities
What: Tests whether a study medicine from Novo Nordisk, cagrisema, can help people with type 2 diabetes lose weight.
Free to join
Who can join: Adults 18+ with obesity, BMI 35+.
Study record on ClinicalTrials.gov
Jackson Clinic, Jackson
Holston Medical Group, Kingsport
CNS Healthcare, Memphis
HealthStar Physicians, PC, Morristown
Clinical Research Associates, Nashville
Weight-loss study of orforglipron
Where: Nashville
What: Tests whether a GLP-1 medicine from Lilly, orforglipron, can help people lose weight.
Free to join
Who can join: Children and teens 6 to 17 with obesity.
Call the site: 615-322-6000Study record on ClinicalTrials.gov
Vanderbilt Health One Hundred Oaks, Nashville. 615-322-6000
Weight-loss study of orforglipron
Where: Nashville
What: Tests whether a GLP-1 medicine from Lilly, orforglipron, can help people lose weight.
Free to join
Who can join: Children and teens 12 to 17 with obesity.
Study record on ClinicalTrials.gov
Vanderbilt Health One Hundred Oaks, Nashville
Show 4 more studies
Weight-loss study of cagrilintide
Where: Memphis
What: Tests whether a study medicine from Novo Nordisk, cagrilintide, can help people lose weight.
Free to join
Who can join: Children and teens 8 to 18 who are overweight.
Study record on ClinicalTrials.gov
LifeDoc Health, Memphis
Weight-loss study of tirzepatide
Where: Nashville
What: Tests whether a GLP-1 and GIP medicine from Lilly, tirzepatide, can help people lose weight.
Free to join
Who can join: Children and teens 6 to 11 with obesity.
Study record on ClinicalTrials.gov
Vanderbilt Health One Hundred Oaks, Nashville
Weight-loss study of LY3305677
Where: Nashville
What: Tests whether an investigational medicine from Lilly, LY3305677, can help people lose weight.
Free to join
Who can join: Adults 18 to 75 with obesity, BMI 27+.
Call the site: 615-835-4750Study record on ClinicalTrials.gov
Quality Medical Research, Nashville. 615-835-4750
Weight-loss study of cagrilintide
Where: Bristol
What: Tests whether a study medicine from Novo Nordisk, cagrilintide, can help people lose weight.
Free to join
Who can join: Adults 18+ with obesity, BMI 30+.
Study record on ClinicalTrials.gov
Holston Medical Group_Bristol, Bristol
Type 2 diabetes studies (6)
Type 2 diabetes study of semaglutide
Where: Memphis and Morristown
What: Tests whether a GLP-1 medicine, semaglutide, can help people with type 2 diabetes lower blood sugar.
Free to join
Who can join: Adults 18+ with type 2 diabetes, BMI 23+.
Study record on ClinicalTrials.gov
Research Site, Memphis
Research Site, Morristown
Type 2 diabetes study of survodutide
Where: Chattanooga and Memphis
What: Tests whether a GLP-1 and glucagon medicine from Boehringer Ingelheim, survodutide, can help people with type 2 diabetes lower blood sugar.
Free to join
Who can join: Adults 18+ with type 2 diabetes, BMI 23+.
Call the site: 833-602-2368Study record on ClinicalTrials.gov
University Diabetes & Endocrine Consultants, Chattanooga. 833-602-2368
LifeDoc Research, PLLC, Memphis. 833-602-2368
Type 2 diabetes study of cagrisema
Where: Memphis
What: Tests whether a study medicine from Novo Nordisk, cagrisema, can help people with type 2 diabetes lower blood sugar.
Free to join
Who can join: Children and teens 10 to 18 with type 2 diabetes.
Study record on ClinicalTrials.gov
LifeDoc Health, Memphis
Show 3 more studies
Type 2 diabetes study of cagrisema
Where: Nashville
What: Tests whether a study medicine from Novo Nordisk, cagrisema, can help people with type 2 diabetes lower blood sugar.
Free to join
Who can join: Adults 18+ with type 2 diabetes, BMI 25+.
Study record on ClinicalTrials.gov
Clinical Research Associates, Nashville
Type 2 diabetes study of NNC0662-0419
Where: Memphis
What: Tests whether an investigational medicine from Novo Nordisk, NNC0662-0419, can help people with type 2 diabetes lower blood sugar.
Free to join
Who can join: Adults 18 to 75 with type 2 diabetes.
Study record on ClinicalTrials.gov
CNS Healthcare, Memphis
Type 2 diabetes study of UBT251
Where: Memphis
What: Tests whether an investigational medicine from Novo Nordisk, UBT251, can help people with type 2 diabetes lower blood sugar.
Free to join
Who can join: Adults 18 to 75 with type 2 diabetes.
Study record on ClinicalTrials.gov
LifeDoc Health, Memphis
Other GLP-1 studies in Tennessee (14)
Fatty liver disease with liver scarring study of survodutide
Where: Chattanooga, Clarksville and Nashville
What: Tests whether a GLP-1 and glucagon medicine from Boehringer Ingelheim, survodutide, can help people reduce liver fat.
Free to join
Who can join: Adults 18+ with fatty liver disease (also called MASH or NASH) with liver scarring (fibrosis).
Call the site: 833-602-2368Study record on ClinicalTrials.gov
ClinSearch, LLC, Chattanooga. 833-602-2368
Innovative Clinical Research, Clarksville. 833-602-2368
Vanderbilt University Medical Center, Nashville. 833-602-2368
Fatty liver disease (also called MASH or NASH) study of survodutide
Where: Chattanooga, Clarksville and Nashville
What: Tests whether a GLP-1 and glucagon medicine from Boehringer Ingelheim, survodutide, can help people reduce liver fat.
Free to join
Who can join: Adults 18+ with fatty liver disease (also called MASH or NASH), BMI 25+.
Call the site: 833-602-2368Study record on ClinicalTrials.gov
ClinSearch, LLC, Chattanooga. 833-602-2368
Innovative Clinical Research, Clarksville. 833-602-2368
Vanderbilt University Medical Center, Nashville. 833-602-2368
Fatty liver disease (MASLD) study of retatrutide
Where: Chattanooga and Cordova
What: Tests whether a GLP-1, GIP and glucagon medicine from Lilly, retatrutide, can help people reduce liver fat.
Free to join
Who can join: Adults 18+ with fatty liver disease (MASLD), BMI 25+.
Call the site: 423-954-9015Study record on ClinicalTrials.gov
Galen Medical Group - Galen Hepatology, Chattanooga. 423-954-9015
Gastro One (Walnut Run Road), Cordova
Show 11 more studies
Peripheral artery disease study of orforglipron
Where: Jackson and Jefferson City
What: Tests whether a GLP-1 medicine from Lilly, orforglipron, can help people improve blood flow in the legs.
Free to join
Who can join: Adults 18+ with peripheral artery disease (poor blood flow in the legs), BMI 23+.
Call the site: 731-660-8396Study record on ClinicalTrials.gov
The Jackson Clinic, Jackson. 731-660-8396
East Coast Institute for Research - Jefferson City, Jefferson City
Prehypertension study of orforglipron
Where: Knoxville and Nashville
What: Tests whether a GLP-1 medicine from Lilly, orforglipron, can help people with prediabetes lose weight.
Free to join
Who can join: Adults 18+ who are overweight, BMI 25+.
Call the site: 865-200-8364Study record on ClinicalTrials.gov
New Phase Research and Development, Knoxville. 865-200-8364
Clinical Research Associates Inc, Nashville. 615-329-0197
Ulcerative colitis study of tirzepatide
Where: Cordova
What: Tests whether a GLP-1 and GIP medicine from Lilly, tirzepatide, can help people with ulcerative colitis calm gut inflammation.
Free to join
Who can join: Adults 18 to 70 with ulcerative colitis, BMI 27+.
Study record on ClinicalTrials.gov
Gastroenterology Center Of The Midsouth, Cordova
Crohn's disease study of tirzepatide
Where: Cordova
What: Tests whether a GLP-1 and GIP medicine from Lilly, tirzepatide, can help people with Crohn's disease calm gut inflammation.
Free to join
Who can join: Adults 18 to 70 with Crohn's disease, BMI 27+.
Study record on ClinicalTrials.gov
Gastroenterology Center Of The Midsouth, Cordova
ASCVD study of semaglutide
Where: Nashville
What: Tests whether a GLP-1 medicine, semaglutide, can help people lower blood sugar.
Free to join
Who can join: Adults 40 to 80 with type 2 diabetes.
Call the site: 615-421-3082Study record on ClinicalTrials.gov
Vanderbilt University Medical Center, Nashville. 615-421-3082
Psoriasis study of tirzepatide
Where: Smyrna
What: Tests whether a GLP-1 and GIP medicine from Lilly, tirzepatide, can help people calm psoriasis.
Free to join
Who can join: Adults 18+ with psoriasis, BMI 27+.
Call the site: 629-895-1775Study record on ClinicalTrials.gov
DelRicht Research - Thompson's Station, Smyrna. 629-895-1775
Prader-Willi syndrome study of tirzepatide
Where: Nashville
What: Tests whether a GLP-1 and GIP medicine, tirzepatide, can help people with Prader-Willi syndrome lose weight.
Free to join
Who can join: Adults 18 to 26 with Prader-Willi syndrome, BMI 30+.
Call the site: 6158754274Study record on ClinicalTrials.gov
Vanderbilt University Medical Center, Nashville. 6158754274
Opioid use disorder study of tirzepatide
Where: Nashville
What: Tests whether a GLP-1 and GIP medicine, tirzepatide, can help people with opioid use disorder cut down on opioids.
Free to join
Who can join: Adults 18+ with opioid use disorder, BMI 23+.
Call the site: 615-585-9889Study record on ClinicalTrials.gov
Vanderbilt University Medical Center, Nashville. 615-585-9889
HIV study of semaglutide
Where: Nashville
What: Tests whether a GLP-1 medicine, semaglutide, can help people with HIV drink less.
Free to join
Who can join: Adults 18 to 89 with HIV, BMI 23+.
Call the site: 615-421-3508Study record on ClinicalTrials.gov
Vanderbilt University Medical Center, Nashville. 615-421-3508
Acute lymphoblastic leukemia study of tirzepatide
Where: Memphis
What: Tests whether a GLP-1 and GIP medicine, tirzepatide, can help survivors of acute lymphoblastic leukemia lose weight.
Free to join
Who can join: Adults 18+ who are survivors of acute lymphoblastic leukemia, BMI 27+.
Call the site: 888-226-4343Study record on ClinicalTrials.gov
St. Jude Children's Research Hospital, Memphis. 888-226-4343
Type 1 diabetes study of semaglutide
Where: Nashville
What: Tests whether a GLP-1 medicine, semaglutide, can help people with type 1 diabetes lower blood sugar.
Free to join
Who can join: Ages 12 to 50 with type 1 diabetes, BMI 18+.
Call the site: (615) 322- 7427Study record on ClinicalTrials.gov
Vanderbilt University Medical Center, Nashville. (615) 322- 7427
Source: ClinicalTrials.gov, the federal registry, read October 16, 2026. Open a study's registry record before you call: it can close to new participants at any time. GLP Chart does not enroll anyone, is not paid for clinical-trial referrals and has no relationship with any sponsor or site on this page.
Clinical trials by state
Every state with a GLP-1 study recruiting today. 48 of them.
- Alabama (18)
- Arizona (22)
- Arkansas (5)
- California (53)
- Colorado (18)
- Connecticut (14)
- Delaware (1)
- District of Columbia (1)
- Florida (43)
- Georgia (23)
- Hawaii (6)
- Idaho (12)
- Illinois (30)
- Indiana (20)
- Iowa (10)
- Kansas (14)
- Kentucky (18)
- Louisiana (14)
- Maine (1)
- Maryland (25)
- Massachusetts (20)
- Michigan (21)
- Minnesota (19)
- Mississippi (7)
- Missouri (22)
- Montana (3)
- Nebraska (7)
- Nevada (11)
- New Hampshire (3)
- New Jersey (11)
- New Mexico (5)
- New York (30)
- North Carolina (31)
- North Dakota (5)
- Ohio (31)
- Oklahoma (12)
- Oregon (5)
- Pennsylvania (33)
- Rhode Island (5)
- South Carolina (25)
- South Dakota (2)
- Tennessee (27)
- Texas (56)
- Utah (14)
- Virginia (28)
- Washington (24)
- West Virginia (5)
- Wisconsin (7)